We reported that the rate of conversion of lactone to carboxylate forms of irinotecan (CPT-11) and its metabolites plays a major role in the biliary excretion of these compounds. Sulfobromophthalein partially inhibited the secretion of SN-38-glucronide into the gastrointestinal lumen, whereas little change was seen in that of active metabolite SN-38. Coadministration of sulphobromophthalein with CPT-11 might lower the late-onset gastrointestinal toxicity observed during treatment with CPT-11 without lowering anticancer activity. In the ileum, the level of transport in the direction form the serosal layer to mucosal layer was signiˆcantly greater than that in the direction form the mucosal layer to serosal layer, whereas a signiˆcant diŠerence was not observed in the jejunum. This secretory transport required metabolic energy was diminished by sulfobromophthalein. A speciˆc transport system plays a major role in the secretion of SN-38 and that this secretory transport system predominantly exists in the ileum. Uptake of SN-38 was signiˆcantly reducted at 4°C. Baicalin inhibited the uptake of SN-38. A speciˆc transport system mediates the uptake of SN-38 across the apical membrane in Caco-2 cells. Inhibition of this transporter would be a useful means for reducing late-onset diarrhea.
CPT-11 (100 mg/body) was injected through the femoral vein. Bile specimens were collected at the speciˆed times. Each value represents the cumulative amounts excreted into bile over periods 0 to 3 hr. Each value is the mean with S.D. p＜0.05 vs i.v. administration of lactone form. 
